252 related items for PubMed ID: 8707781
1. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, Kellerman DJ.
J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
[Abstract] [Full Text] [Related]
2. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
3. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A.
Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
[Abstract] [Full Text] [Related]
4. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[Abstract] [Full Text] [Related]
5. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ.
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
[Abstract] [Full Text] [Related]
6. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF, Pearlman DS, Ruff ME, Silvers WS, Weinstein SW, Clements DS, Brown A, Duke S, Harding SM, House KW.
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[Abstract] [Full Text] [Related]
7. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
8. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B, Bonnaud G, Haahtela T, Luna JM, Querfurt H, Wegener T, Lutsky BN.
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[Abstract] [Full Text] [Related]
9. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A.
J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
[Abstract] [Full Text] [Related]
10. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, Faris MA, Crim C.
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[Abstract] [Full Text] [Related]
11. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
Pieters WR, Stallaert RA, Prins J, Greefhorst AP, Bosman HG, van Uffelen R, Schreurs AJ, van Helmond JL, Janssen PG.
J Asthma; 1998 Jun; 35(4):337-45. PubMed ID: 9669827
[Abstract] [Full Text] [Related]
12. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
[Abstract] [Full Text] [Related]
13. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug 29; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
14. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
J Allergy Clin Immunol; 2001 Mar 29; 107(3):461-8. PubMed ID: 11240946
[Abstract] [Full Text] [Related]
15. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
J Allergy Clin Immunol; 2000 Dec 29; 106(6):1088-95. PubMed ID: 11112891
[Abstract] [Full Text] [Related]
16. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K, Noonan M, Silkoff PE, Uryniak T.
Clin Ther; 2007 Jun 29; 29(6):1013-26. PubMed ID: 17692718
[Abstract] [Full Text] [Related]
17. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
J Asthma; 2007 Jun 29; 44(6):437-41. PubMed ID: 17654129
[Abstract] [Full Text] [Related]
18. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW, Prenner B, Berkowitz R, Galant S, Ramsdell J, Lutsky B.
Ann Allergy Asthma Immunol; 2006 Apr 29; 96(4):533-40. PubMed ID: 16680923
[Abstract] [Full Text] [Related]
19. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B, Rönmark E, Lindberg A, Jonsson AC, Larsson LG, Pétavy F, James M.
Respir Med; 2006 Jan 29; 100(1):2-10. PubMed ID: 16243498
[Abstract] [Full Text] [Related]
20. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.
Ann Allergy Asthma Immunol; 1999 Feb 29; 82(2):205-11. PubMed ID: 10071526
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
